ARTICLE | Company News
Amorsa, J&J deal
January 6, 2017 10:03 PM UTC
The Janssen Pharmaceuticals Inc. unit of Johnson & Johnson partnered with Amorsa to develop therapies for treatment-resistant depression. The partners will use the biotech's ketamine analog technology...